Abstract

Pseudomonas aeruginosa is a ubiquitous microorganism that is difficult to treat due to the increasing prevalence of multidrug resistance patterns. A total of 227 samples were taken from different clinical samples during the study period from January 2018 to December 2018. The isolates were identified with antibiotic sensitivity testing with ESBL by the Vitek-2 automated method. MDR, XDR, and PDR were determined. 40 (17.6%) isolates were positive for P. aeruginosa, maximum of ESBL and MBL. Positive isolates were detected in the burn, coexisting ESBL + MBL enzymes in 21 (52.5%) of our isolates. Imipenem followed by Meropenem were found to be effective against ESBL and MBL producers. Resistance was reached between 72-100% to 5 antibiotics. The frequency of PDR, MDR, and XDR were 5%, 50%, and 45%, respectively. The frequency of co-production between MDR, XDR, and PDR with MBL, ESBL, and Biofilm was 35%, 12.5% and 5%, respectively. Among the ESBLs, the frequency of distribution of blaVEB-1gene and blaGES-5 gene was 50% and 40 %, respectively. Bacterial isolates simultaneously carrying blaVEB-1 gene with multiple β-lactamases of different classes of biofilm, MDR, PDR, and XDR as same as a coexisting blaGES-5 gene. One isolate was detected as new isolates registered in global gene bank as locally P. aeruginosa isolates in Erbil city (LOCUS MN900953). The phylogenetic trees of the blaVEB gene isolates were demonstrated a genotype closely related to others, deposited in GenBank similar to the P. aeruginosagene; gene sequencing revealed a 99% similarity with other isolates deposited in GenBank.

Highlights

  • Pseudomonas aeruginosa is the major cause of nosocomial infection in medical settings, bringing about severe infection in patients with background diseases [1]

  • multi-drug resistant (MDRs), XDR, and Pandrug resistant (PDR) were determined. 40 (17.6%) isolates were positive for P. aeruginosa, maximum of ESBL and MBL

  • ESBLs are a group of enzymes produced by certain microorganisms with the ability to hydrolyze a broad range of β-lactams, including penicillins, cephalosporins, and aztreonam, whereas cannot hydrolyze cephamycins and carbapenems (i.e., Imipenem) professionally.In general, ESBLs are not codified by the bacterial chromosome but are usually codified by transferable plasmids

Read more

Summary

Introduction

Pseudomonas aeruginosa is the major cause of nosocomial infection in medical settings, bringing about severe infection in patients with background diseases [1]. The frequency of co-production between MDR, XDR, and PDR with MBL, ESBL, and Biofilm was 35%, 12.5% and 5%, respectively.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.